Comparative efficacy, tolerability and acceptability of intravenous racemic ketamine with intranasal esketamine, aripiprazole and lithium as augmentative treatments for treatment-resistant unipolar depression: A systematic review and network meta-analysis-Reference-Cited by-同舟云学术

Comparative efficacy, tolerability and acceptability of intravenous racemic ketamine with intranasal esketamine, aripiprazole and lithium as augmentative treatments for treatment-resistant unipolar depression: A systematic review and network meta-analysis

Published:2024-02 Issue: Volume:346 Page:49-56
ISSN:0165-0327
Container-title:Journal of Affective Disorders
language:en
Short-container-title:Journal of Affective Disorders

Author:

Terao Itsuki^ORCID,Tsuge Takahiro^ORCID,Endo Kaori^ORCID,Kodama Wakako^ORCID

Publisher

Elsevier BV

Subject

Psychiatry and Mental health,Clinical Psychology

Reference47 articles.

1. Comprehensive assessment of side effects associated with a single dose of ketamine in treatment-resistant depression;Acevedo-Diaz;J. Affect. Disord.,2020

2. Comparative efficacy of racemic ketamine and esketamine for depression: a systematic review and meta-analysis;Bahji;J. Affect. Disord.,2021

3. A double-blind, placebo-controlled study of citalopram with and without lithium in the treatment of therapy-resistant depressive patients: a clinical, pharmacokinetic, and pharmacogenetic investigation;Baumann;J. Clin. Psychopharmacol.,1996

4. The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: a multicenter, randomized, double-blind, placebo-controlled study;Berman;J. Clin. Psychiatry,2007

5. Aripiprazole augmentation in major depressive disorder: a double-blind, placebo-controlled study in patients with inadequate response to antidepressants;Berman;CNS Spectr.,2009

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ketamine and its two enantiomers in anesthesiology and psychiatry: A historical review and future directions;Journal of Anesthesia and Translational Medicine;2024-09

2. Efficacy and safety of esketamine for perioperative depression in patients undergoing elective surgery: A meta-analysis of randomized controlled trials;Asian Journal of Psychiatry;2024-05

3. Antwort zum Leserbrief: Ketamininfusionstherapie zur Behandlung von Depressionen – Schritt für Schritt;PSYCH up2date;2024-05

4. Clinical characteristics and treatment exposure of patients with marked treatment-resistant unipolar major depressive disorder: A RECOVER trial report;Brain Stimulation;2024-03

5. Are “mystical experiences” essential for antidepressant actions of ketamine and the classic psychedelics?;European Archives of Psychiatry and Clinical Neuroscience;2024-02-27